Sequent Scientific Limited (NSE:SEQUENT)
India flag India · Delayed Price · Currency is INR
168.61
-3.36 (-1.95%)
Aug 1, 2025, 3:30 PM IST

Sequent Scientific Company Description

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally.

The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of antihelmentic, anti-parasites, antiprotozoal, NSAID, anti-bacterial, phosphorus supplement, beta agonist, analgesic, antimetic, anti- allergic, and congestive heart failure.

It also offers analytical services; and finished dosage formulations, and VET formulation. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009.

The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.

Sequent Scientific Limited
CountryIndia
Founded1985
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,244
CEORajaram Narayanan

Contact Details

Address:
Dosti Pinnacle
Mumbai, 400604
India
Phone91 22 4111 4777
Websitesequent.in

Stock Details

Ticker SymbolSEQUENT
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE807F01027
SIC Code2834

Key Executives

NamePosition
Rajaram NarayananMD, Chief Executive Officer and Director
Saurav BhalaChief Financial Officer
Phillip TrottAssoc. Vice President, Head of Legal and Chief Risk Officer
Yoshita VoraCompany Secretary and Compliance Officer
Vedprakash RagateExecutive Director
Ramesh Kumar PillaiCorporate Vice President of Ra Qa and Technical Services
Ravi NairExecutive Vice President of Human Resources and Administration
Abhishek SinghalHead of Investor Relations
Prasad LadVice President of Human Resources and Administration